17 molecular-modelling Postdoctoral positions at University of Nebraska Medical Center
Sort by
Refine Your Search
-
Listed
-
Field
-
with disabilities. Location Omaha, NE Requisition Number: 2025 - 259 Department Biochem and Molecular Biology 50000510 Business Unit(College/Institute) College of Medicine FTE: 100 Reg-Temp Full-Time
-
: 94057 Requisition Number: 2025 - 259 Business Unit: College of Medicine Department: Biochem and Molecular Biology 50000510 Reg-Temp: Full-Time Regular Position Summary: The Department of Biochemistry and
-
molecular mechanisms driving lymphoma progression and therapy resistance. This position will leverage cutting-edge approaches including spatial transcriptomics, CRISPR-based functional genomic screening, and
-
research, with a focus on understanding the molecular mechanisms driving lymphoma progression and therapy resistance. This position will leverage cutting-edge approaches including spatial transcriptomics
-
immunology and molecular biology techniques. Preferred experiences are with mouse models of kidney injury and microsurgical skills in particular. Successful applicant’s work will include investigation
-
brain cancer) with its most aggressive form. This lab is seeking a highly motivated postdoctoral candidate with expertise in the molecular cell biology and animal model studies. The candidate should be
-
vitro and in vivo models of congenital heart defects. This individual will complete projects that require expertise in iPSC biology and derivation of terminal cell types, methods of molecular biology
-
, University of Nebraska Medical Center (Omaha), seeks a postdoctoral research associate to join Dr. Hingorani’s lab. Our laboratory investigates molecular and cellular mechanisms of pancreatic ductal
-
in iPSC biology and derivation of terminal cell types, methods of molecular biology, gene transfer, gene editing, biochemistry, cell biology, cell culture, and vertebrate animal models, including
-
and working experience in BSL2, BSL3 and ABSL2 and ABSL3 labs preferred. Research interests include animal models as synergetic platform for preclinical development of therapeutics and molecular biology